The global biotech market which was $1023.92 billion in 2022, is expected to reach $10129.16 billion by 2030. Unlike many sectors, biotech attracted record levels of investment during COVID. Japan and Korea, two of the largest Asian markets, present a host of opportunities. Hear from key industry speakers from both markets to learn of best..
Tri-Valley is rich with expertise in developing life sciences tools, diagnostics, and med tech devices. That is why California Life Sciences (CLS) FAST advisory program for life sciences entrepreneurs is reaching out to our region with Daybreak Labs, the Tri-Valley's first life sciences and hard tech incubator. Shikha Sharma, PhD, Innovation & Entrepreneurship at California Life..
We are delighted to share with you that on May 18 WuXi AppTec cohosted the successful inaugural WuXi Innovation Day in Singapore that spotlights the region’s strengths and opportunities in advancing innovation that matters to patients and the future of health. We appreciate this collaborative partnership with Agency for Science, Technology, and Research (A*STAR) and SGX..
The University of California at San Francisco (UCSF) and City College of San Francisco (CCSF) are partnering with the California Life Sciences (CLS) through its Racial & Social Equity (RSE) work to deliver a third pilot aimed at helping life science organizations build inclusive management practices and workplaces. This training is designed to teach current..
The University of California at San Francisco (UCSF) and City College of San Francisco (CCSF) are partnering with the California Life Sciences (CLS) through its Racial & Social Equity (RSE) work to deliver a third pilot aimed at helping life science organizations build inclusive management practices and workplaces. This training is designed to teach current..
The University of California at San Francisco (UCSF) and City College of San Francisco (CCSF) are partnering with the California Life Sciences (CLS) through its Racial & Social Equity (RSE) work to deliver a third pilot aimed at helping life science organizations build inclusive management practices and workplaces. This..
Are you a research entrepreneur or small business focused on translational science? Join the California Life Sciences (CLS) and the Center for Scientific Review (CSR) In collaboration with the National Center for Advancing Translational Sciences (NCATS) for a webinar on small business funding opportunities. Learn more about non-dilutive Small..
In cardiovascular clinical trials, the primary endpoint often consists of multiple survival outcomes. These outcomes are commonly evaluated by a time-to-first event composite endpoint analysis. A time-to-first event analysis, however, has shortcomings in evaluating a treatment effect. It emphasizes each patient’s first event, which is often the outcome of lesser clinical importance. In addition, it..
The University of California at San Francisco (UCSF) and City College of San Francisco (CCSF) are partnering with the California Life Sciences (CLS) through its Racial & Social Equity (RSE) work to deliver a third pilot aimed at helping life science organizations build inclusive management practices and workplaces. This..
